Regulatory guidance and validation science for digital endpoints are solid. The real barrier is cross-functional execution – and the cost of waiting is compounding.
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Fast Data Insights Improve Productivity, Client Centricity
Discover how Medidata's Rave CTMS seamlessly met the comprehensive requirements of Catalyst Clinical Research—an exclusive CRO provider specializing in oncology—during a period of rapid expansion.
-
Clinical Trial Technology Report Showcases 2023 Trends: Site Enablement, eISFs, And Integrations
Dive into six insights to stay on top of the rapidly shifting research industry and to ensure your research organization doesn’t get left behind.
-
Using RWE To Get To Insights And Action — Faster
Delve into three examples that vividly showcase the formidable power of real-world evidence from the early stages of drug development through clinical trials and commercialization.
-
Phase 4 Trials: A Critical Component Of Post-Marketing Insight
Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.
-
Fast, Focused Medical Data Review: Use Cases By A Medical Monitor
See how the right data visualization tool can help medical monitors tailor and improve their data review processes and enhance their ability to identify safety signals both quickly and surely.
-
Real-World Evidence - Where Are We Now?
Notwithstanding ongoing confusion over the concepts of “real-world data” and “real-world evidence” in 2022, more than 5 years after the passage of the 21st Century Cures Act, the FDA continues to evaluate such data and evidence as it considers regulatory decisions.
-
How Site eSource Completes And Extends The EHR To EDC Initiative
This study evaluates to what degree an eSource-to-EDC data transfer initiative succeeds through two key dimensions: "Mappability" and "Prevalence".
-
Avoiding Vaporware – Even More Questions To Ask eClinical Platform Providers
For a platform that aligns with the demands of modern clinical research, delve into these considerations to ensure your choice supports your study’s success.
-
How To Optimize Adherence Of Wearables In Your Clinical Research
Learn about the top three factors to consider when working to maximize protocol adherence and minimize missing data in a technology-enabled clinical trial.
-
Introducing Digitally-Enabled Biosample Consent Storage
Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- Sites Are Building Their Own Tech – SCRS On What That Means
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
RECENT NEWSLETTERS
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data